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The adaptor protein SLP76 directs signaling down-
stream of the T cell receptor (TCR) and is essential
for thymocyte development. SLP76 contains three
N-terminal tyrosines that are critical for its function.
To define the role of these residues in thymocyte
development, we generated two lines of ‘‘knock-in’’
mice, one expressing a mutation in tyrosine 145
(Y145F) and a second harboring two point mutations
at tyrosines 112 and 128 (Y112-128F). We show here
that although thymocyte development requires both
Y145- and Y112-128-generated signals, selection
was more dependent upon Y145. Although several
proximal TCR signaling events were defective in
bothmutantmice, phosphorylationof theguaninenu-
cleotide exchange factor, Vav1, and activation of
Itk-dependent pathways were differentially affected
by mutations at Y112-128 and Y145, respectively.
Analysis of mice expressing one Y145F and one
Y112-128F allele revealed that these mutants could
complement one another in trans, demonstrating co-
operativity between two or more SLP76 molecules.
Thus, the N-terminal tyrosines of SLP76 are required
for thymocyte selection but can function on separate
molecules to support TCR signaling.
INTRODUCTION
During development, thymocytes pass through several check-
points. T cell progenitors enter the thymus as double-negative
(CD4–CD8– [DN]) cells and progress in a T cell receptor (TCR)-
independent manner through the DN1 (c-kit+CD25–), DN2
(c-kit+CD25+), and DN3 (c-kit–CD25+) stages (Godfrey and
Berzins, 2007). At the DN3 stage, the pre-TCR is expressed,
and signaling through this receptor is required for the transitionto the final DN (DN4: ckit–CD25–) and double-positive stages
(CD4+CD8+ [DP]). Only thymocytes with intact pre-TCR signaling
pass this checkpoint, known as b-selection, and undergo prolif-
eration and differentiation to become DP cells, at which time the
mature ab TCR is expressed (Michie and Zuniga-Pflucker, 2002).
This TCR is tested during positive and negative selection, a sec-
ond developmental stage in which intact TCR signaling is re-
quired (Miosge and Zamoyska, 2007). DP thymocytes capable
of interacting with self-MHC ligands with sufficient avidity are
positively selected to mature into either CD4 single-positive
[CD4+CD8– (CD4SP)] or CD8 single-positive [CD4–CD8+
(CD8SP)] thymocytes, whereas those whose avidity is too strong
are signaled to die by apoptosis. Collectively, these processes
generate a diverse T cell repertoire that is optimized for recogni-
tion of self-MHC complexed with foreign peptides.
Selection of T cells is governed by signals through the TCR or
pre-TCR. After TCR stimulation, the immunoreceptor tyrosine-
based activation motifs (ITAMs) of the CD3 chains are phosphor-
ylated by Src protein tyrosine kinases (PTK), allowing for the
recruitment of Syk family PTKs (Syk or ZAP-70), which subse-
quently phosphorylate key adaptor proteins. These adaptor
proteins lack enzymatic activity but aid in the localization and
activation of enzymes required for the generation of second
messengers and signal propagation (Jordan et al., 2003).
The SH2 (Src homology 2)-domain-containing leukocyte
phosphoprotein of 76 kDa (SLP76) is one adaptor protein that
is critical for thymocyte development. Mice lacking SLP76
exhibit a block at the DN3/DN4 transition, resulting in no
DP or mature T cells (Clements et al., 1998; Pivniouk et al.,
1998) and no natural killer (NK) T cells (K.N., unpublished data).
SLP76 has four functional domains: an N-terminal sterile amotif
(SAM) domain, a C-terminal SH2 domain, a central proline-rich
region, and an N-terminal acidic domain containing tyrosines
at positions 112, 128, and 145 that are phosphorylated after
TCR stimulation. Tyrosines 112 and 128 are both part of a
YESP motif and have been shown in Jurkat cells to bind to the
guanine nucleotide exchange factor Vav1 and the adaptor pro-
tein Nck (Bubeck Wardenburg et al., 1998; Raab et al., 1997;
Wu et al., 1996). Tyrosine 145 lies within a YEPP motif and hasImmunity 28, 359–369, March 2008 ª2008 Elsevier Inc. 359
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Trans Complementation of SLP76 Knock-In Mutationsbeen implicated in binding IL-2 inducible T cell kinase (Itk) (Bun-
nell et al., 2000; Su et al., 1999). Through structural and func-
tional studies, the N-terminal tyrosines of SLP76 have been
shown to be most critical for the function of this adaptor. Muta-
tion of all three tyrosines in Jurkat cells leads to defective Ca2+
release and MAPK activation (Musci et al., 1997; Yablonski
et al., 2001). In vivo, transgenic expression of a Y112-128-
145F (Y3F) SLP76 mutant on a SLP76-deficient background
leads to DP but very few mature SP thymocytes and a 90%
reduction in thymus size (Kumar et al., 2002; Myung et al., 2001).
Given the central role of the N-terminal tyrosines in the func-
tion of SLP76, we investigated their individual functions by using
the Jurkat model system (Jordan et al., 2006). These studies
identified tyrosine 145 as the most important individual tyrosine
for mediating TCR signal transduction. To determine the impact
of this tyrosine in vivo, we generated ‘‘knock-in’’ mice that con-
tain a tyrosine to phenylalanine (Y/F) mutation at position 145
of SLP76. A second, complementary mouse containing Y/F
mutations at the remaining two tyrosines residues (112 and
128) was also generated. Both mutant mice demonstrate defec-
tive positive and negative selection, NKT cell development,
T cell:APC conjugate formation, and activation of several proxi-
mal signaling molecules. However, thesemutants show differen-
tial activation of Vav1- and Itk-dependent pathways. Addition-
ally, we found that when these two mutants are coexpressed,
they are able to rescue one another in trans. Thus, thymocyte
development is dependent upon tyrosine phosphorylation of
SLP76, but these tyrosines are not required to be on the same
SLP76 molecule.
RESULTS
Generation of SLP76 Mutant Mice
To determine how mutation at Y145 of SLP76 affects thymocyte
development, we generated mice that carry a single-nucleotide
point mutation (an A/T substitution resulting in altering a tyro-
sine to phenylalanine) at this position. As a complementary
mutation, we generated a mouse with tyrosine-to-phenylalanine
substitutions at the other N-terminal sites Y112 and Y128 (Fig-
ures S1A and S1B in the Supplemental Data available online).
Flow cytometry (Figure S1C) showed that SLP76 protein expres-
sion was not altered as a result of targeting exon 7. Both Y145F
and Y112-128F mice were generated at Mendelian ratios, and
there was no evidence of the perinatal lethality (Clements
et al., 1998) and vascular defects (Abtahian et al., 2003) that
are observed in SLP76-deficient mice.
Thymocyte Development in SLP76 Mutant Mice
Y145F and Y112-128F mutant mice were both capable of gener-
atingmatureSP thymocytes (Figure 1A). Although thereweremild
decreases in total thymic cellularity and subtle differences in
the percentage of thymocytes within the DN, DP, CD4SP, and
CD8SP stages when these mutants were compared to wild-type
mice, there were significant differences in the CD4SP:CD8SP
ratio between wild-type and both mutant lineages (Table S1).
Further analysis of the DN stages revealed that Y145F and
Y112-128F mice have a partial defect in transitioning from DN3
to DN4 (Figure 1A), the stage at which SLP76-deficient mice
display a complete block (Clements et al., 1998).360 Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc.In addition to conventional ab T cells, the thymus also gener-
ates NKT cells. Most NKT cells express an invariant TCRa chain
(Va14-Ja18) in combination with particular Vb chains and can be
identified by positive staining with glycolipid-antigen-loaded
CD1d tetramers. Although the early stages of NKT cell develop-
ment proceed in large part in the thymus, final maturation might
occur in the periphery (Godfrey and Berzins, 2007). Thus, using
tetramers loaded with an analog of a-galactosyl-ceramide
(PBS57) to identify NKT cells and CD44 and NK1.1, markers of
early and late NKT cell maturation, respectively, we analyzed
NKT cell development in wild-type and SLP76 mutant mice.
The frequency and absolute number of thymicNKT cellswere de-
creased in Y112-128Fmice and to a greater extent in Y145Fmice
(Figures 1B and 1C). Although the percent of CD44+ cells was
only slightly decreased among mutant versus wild-type NKT
cells, NK1.1 expression was markedly diminished. This defect
was even more pronounced in the spleen and liver (Figure 1C).
Thus, in addition to defects in ab T cell development, NKT cell
development in SLP76 mutant mice is substantially altered.
Defective Negative Selection
of SLP76 Mutant Thymocytes
As thymocytes transition from DN to DP, they upregulate CD5,
CD2, and CD3 expression in response to pre-TCR and TCR sig-
naling (Azzam et al., 1998; Duplay et al., 1989). Although CD3
expression was similar between wild-type and mutant mice at
this stage, upregulation of CD5 and CD2 failed to occur in both
Y145F and Y112-128F thymocytes, indicating that signaling
from the pre-TCR is defective (Figure 2A and data not shown).
Progression to the SP stage is accompanied by further increases
in thesemolecules (Duplay et al., 1989; Tarakhovsky et al., 1995).
Despite their severe defect in CD5 and CD2 expression at the DP
stage, SP thymocytes from Y112-128F mice showed normal
CD5, CD2, and CD3 expression, and Y145F SP thymocytes
showed only slightly reduced expression of these molecules
(Figure 2A and data not shown). Because CD5 expression corre-
lates directly with TCR affinity, the shift in CD5 expression at the
DP stage in the mutant mice suggests that TCR signaling was
dampened (Azzam et al., 1998).
To investigate the ability of mutant thymocytes to undergo
negative selection, we assessedwhether mutant DP thymocytes
could upregulate the orphan nuclear receptor Nur77 after in vitro
stimulation. Nur77 is induced in DP thymocytes subjected to
apoptotic signals in vitro (TCR and CD28 coligation) and in re-
sponse to negatively selecting ligands in vivo (Cho et al., 2003;
Cunningham et al., 2006). Nur77 was robustly induced in wild-
type DP thymocytes but only weakly upregulated in Y145F and
Y112-128F DP thymocytes after in vitro stimulation (Figure 2B).
In vitro stimulation of mutant thymocytes also resulted in dimin-
ished down-modulation, or ‘‘dulling,’’ of CD4 and CD8 on DP
thymocytes as compared to wild-type thymocytes (Figure 2C).
DP dulling occurs on apoptotic thymocytes (Kishimoto et al.,
1995) and on thymocytes transitioning to the SP stage (McGargill
and Hogquist, 1999) and has been used as an indicator of both
negative- and positive-selection events. Thus, the reduction
of DP dulling in mutant thymocytes is consistent with altered
thymocyte signaling and possible defects in selection.
To more directly address the efficiency of negative selection in
SLP76 mutant mice, we assessed deletion of Vb11+ and Vb12+
Immunity
Trans Complementation of SLP76 Knock-In MutationsFigure 1. Altered Thymic Development in SLP76 Mutant Mice
(A) Thymocytes from wild-type, Y145F, and Y112-128F mice were stained with anti-CD4 and anti-CD8 so that DN, DP, and SP populations could be determined.
Contour plots (top row) are representative of 25 mice. DN1-DN4 populations were determined by analysis of CD25 versus c-kit expression on thy1.2+ lineage
(lineage gate consisted of antibodies directed to CD8, B220, DX5, NK1.1, TCRgd, Mac1, and Gr1) thymocytes (n = 5).
(B) Thymic NKT cells were defined as PBS57–CD1d tetramer (Tet)+TCRb+ cells (n = 4).
(C) The absolute number (avg ± SD) of NKT cells from the thymus, spleen, and liver was calculated from the total live cell number of each organ and the percent of
Tet+TCRb+ cells (n = 4). A Student’s t test was used for determining significance. Comparison of wild-type and Y112-128F for the thymus, spleen, and liver, re-
spectively is as follows: p = 0.067, p = 0.25, and p = 0.002. Wild-type versus Y145F for these organs is as follows: p = 0.01, p = 0.02 and p = 0.0008. Contour plots
show CD44 versus NK1.1 on thymocytes, splenocytes, and liver tet+TCRb+ cells (n = 4).three-fold increase in thymic size compared to that of wild-type
male mice (Figure S2). Thus, the N-terminal tyrosines of SLP76,
especially Y145, are required for proper negative selection.
Defective Positive Selection in Mutant Mice
Positive selection in SLP76mutant mice was determined by their
ability to select theMHC class II-restricted AND TCR (Kaye et al.,
1989). In wild-type AND+ mice, CD4SP cells represent, on aver-
age, 37% of the thymus, and nearly all express high amounts of
the transgenic TCR (Figure 3A). This expression was reduced to
4.8% and 2.3% in Y112-128F and Y145F mice, respectively.
Although both mutant strains demonstrated substantial defects
in positive selection, these defects were more profound in
the Y145F lineage, as evidenced by an approximate 75% loss
of Va11-Vb3 transgenic TCR expression among CD4SP thymo-
cytes as compared to wild-type CD4SP, a reduction far greater
than that observed in Y112-128F mice. Costaining with a
pan anti-TCRb reagent revealed that the low Vb3 expression inthymocytes in I-Ed+miceexpressingMMTV-8and -9. Inwild-type
miceandY112-128Fheterzygotes, Vb11+andVb12+ thymocytes
underwent superantigen-induced deletion from theDP toCD4SP
stage (Figure 2D). In contrast, Y145F mice failed to delete Vb11+
and only partially deleted Vb12+ thymocytes. Y112-128F thymo-
cytes also showed defects in superantigen-mediated deletion
but to a lesser extent than Y145F thymocytes. Thymocytes
expressing nonsusceptible Vb chains (Vb8 and Vb6) were found
at expected frequencies (Figure 2D and data not shown).
Negative selection of MHC class I-restricted thymocytes
through peptide:MHC interactions was assessed in male HY
TCR transgenic mice (Teh et al., 1989). In this model, thymocyte
development is arrested at the DN stage in wild-type male mice
(Takahama et al., 1992). This block was substantially alleviated
in Y112-128F and Y145F mice, allowing for maturation to the DP
stage and, in the case of Y145F mice, development into CD8SP
cells (Figures 2E and S2). The increased proportion of DP and
CD8SP populations in Y145F mice was accompanied by aImmunity 28, 359–369, March 2008 ª2008 Elsevier Inc. 361
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Trans Complementation of SLP76 Knock-In MutationsFigure 2. Thymocyte Selection in SLP76 Mutant Mice Is Altered
(A) CD5 and CD3 expression is shown on DN, DP, CD4SP, and CD8SP thymocytes (n > 10). Mutant mice are represented by the shaded histogram.
(B) Nur77 expression was measured by flow cytometry on DP thymocytes cultured with anti-CD3, anti-CD3 + anti-CD28, or no stimuli for 2 hr (n = 6–7).
(C) DP dulling was measured on thymocytes cultured for 5 hr. Dot plots show the percent of DPhi and DPlo cells within the DP population (n = 5).
(D) DP and CD4SP thymocytes from wild-type, mutant, and Y112-128F heterozygous mice expressing MHCd were evaluated for expression of Vb12, 11, and 8.
The percent of these Vb chains among DP and CD4SP populations is shown (n = 5–10 mice per genotype). p values from a Student’s t test are shown. Error bars
indicate the standard deviation.
(E) Thymi from male HY TCR transgenic mice were stained with antibodies to CD4 and CD8. (n = 2–6 mice per group).Y145Fmice was not due to the use of endogenous Vb chains but
rather to overall reduced TCR expression (data not shown).
Despite low TCRb expression, CD4SP thymocytes from Y145F
mice were HSAlo, indicating that these cells were mature (data
not shown) (Crispe and Bevan, 1987).
Intact thymocyte selection correlates with the ability of DP
thymocytes to form conjugates with antigen-presenting cells (Ar-
douin et al., 2003; Richie et al., 2002;Wu et al., 2006). To examine
this function in SLP76 mutant mice, we incubated thymocytes
from wild-type and mutant mice expressing the AND transgene
with pigeon cytochrome c (PCC) peptide (the antigen recognized
by AND transgenic T cells)-pulsed B cells. Because the expres-
sion of the AND transgenic TCR is lower on mutant compared
to wild-type thymocytes, we focused our analysis on cells ex-
pressing the same level of Va11. DP thymocytes from both mu-362 Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc.tant mice formed fewer conjugates than wild-type thymocytes
(Figure 3B). Consistent with decreased TCR-induced conjugate
formation, Y112-128F and Y145F thymocytes were impaired
in TCR-induced actin polymerization (Figure 3C), a process re-
quired for conjugate formation (Huang and Burkhardt, 2007).
Thus, the defects seen in both positive and negative selection
in Y145F and Y112-128F mice might be partly due to defective
interactions with thymic antigen-presenting cells.
Proximal TCR Signaling Is Defective
in SLP76 Mutant Mice
Mutation of tyrosine residues within the N terminus of SLP76 is
predicted to lead to loss of SLP76 phosphorylation. Indeed,
mutation of Y112 and Y128 ablated nearly all detectable
SLP76 phosphorylation (Figure 4A); mutation of Y145, however,
Immunity
Trans Complementation of SLP76 Knock-In MutationsFigure 3. Positive Selection and Conjugate Formation Are Defective in Mutant Mice
(A) The top contour plots show the CD4 versus CD8 profile of total thymocytes fromwild-type, Y112-128F, and Y145F AND TCR transgenic mice (n = 4–9). DP and
CD4SP populations were evaluated for expression of the transgenic receptor Vb3Va11. Numbers represent the percent of the gated population.
(B) Contour plots show Va11 versus B220 expression on DP thymocytes stimulated with PCC loaded (bottom) or nonloaded (top) B cells. Numbers represent the
percent of cells that form conjugates with B220+ B cells and the percent that do not among a population of thymocytes expressing the same amount of Va11
(n = 3–4 mice per genotype).
(C) Actin polymerization was measured in CD4SP thymocytes by flow cytometry after TCR stimulation for 0 min (shaded histogram), 2 min, or 7 min (black line).
Numbers represent the mean fluorescence intensity of the unstimulated (Un) or stimulated peaks. Data are representative of four experiments.resulted in little diminishment of total phosphorylation. These
data are consistent with our previous studies in Jurkat cells.
In these studies, Y145 was shown to be phosphorylated, but
optimal phosphorylation occurred only when Y112 or Y128
were intact (Jordan et al., 2006). It is unclear why the Y112-
128F mutant does not have a more severe phenotype than the
Y145Fmouse. It is possible that little phosphorylation is required
for Y145 function or that Y145 supports phosphorylation-inde-
pendent functions. SLP76 phosphorylation was also analyzed
with a pY128-specific antibody. Stimulated Y112-128F thymo-
cytes failed to react with the pY128 antibody, whereas wild-
type and Y145F thymocytes were capable of phosphorylating
this site (Figure 4B). Global loss of tyrosine phosphorylation
was not observed in either mutant; rather, loss of phosphoryla-
tion of a 95kDa species was noted in Y112-128F thymocytes
(Figure 4C). To probe whether events upstream of SLP76 were
intact, we assessed TCR-induced phosphorylation of tyrosine
191 on LAT and found this process to be normal in both mutants
(Figure 4B).
To address the biochemical mechanism(s) underlying the
selection defects observed in SLP76 mutant mice, we analyzed
phospholipase-Cg1 (PLCg1) phosphorylation, Ca2+ flux, and
ERK phosphorylation after TCR stimulation. In unfractionated
thymocytes, PLCg1 and ERK phosphorylation weremarkedly di-
minished in both mutant mice after TCR stimulation (Figures 4Dand 4E). Similar defects in ERK phosphorylation were noted in
purified DP thymocytes after TCR and CD4 co-crosslinking (Fig-
ure S3), and Ca2+ flux was diminished in both DP and CD4SP
thymocytes (Figure 4F). Tyrosines 112 and 128 of SLP76 have
been shown in Jurkat cells to be the sites responsible for induc-
ible Vav1 association (Raab et al., 1997; Wu et al., 1996). Thus,
we were surprised to find that in primary wild-type thymocytes
SLP76 and Vav1 coassociation occurred independently of
SLP76 phosphorylation. Moreover, this association was also
present in Y112-128F thymocytes (Figure S4A). However, we
did observe that there was a near complete loss of TCR-induced
Vav1 phosphorylation in Y112-128F thymocytes (Figure 5A),
consistent with the loss of a phosphorylated species at 95 kDa
as seen by anti-phosphotyrosine (Figure 4C). Importantly, there
was only a mild decrease in Vav1 phosphorylation in Y145F
thymocytes.
Similar to the preserved binding of SLP76 and Vav1 in Y112-
128F thymocytes, mutation of Y145 (the proposed Itk phosphor-
ylation-dependent binding site on SLP76) did not result in loss
of SLP76 or Itk association (Figure S4B). In Jurkat cells it was re-
cently shown that the N-terminal tyrosines of SLP76 are respon-
sible for Itk phosphorylation and activation and that catalytically
active Itk was preferentially associated with SLP76 (Bogin et al.,
2007). Thus, tyrosine 145 may be responsible for activating Itk. If
this scenario is correct, then the phenotype of Y145Fmice wouldImmunity 28, 359–369, March 2008 ª2008 Elsevier Inc. 363
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Trans Complementation of SLP76 Knock-In MutationsFigure 4. Mutant Thymocytes Have Diminished Phosphorylation of PLCg1 and ERK and Diminished Ca2+ Flux in Response to TCR
Stimulation
(A–E) Thymocytes were stimulated for the indicated times or with pervanadate (PV) for 3 min. In (A), SLP76 was immunoprecipitated from the lysates;
immunoprecipitations were immunoblotted for total tyrosine phosphorylation with 4G10. SLP76was used as a loading control (n = 3). In (B)–(E), thymocyte lysates
were immunoblotted with the indicated antibodies. Antibodies against total PLCg1 or ERK2 were used as loading controls (n = 5).
(F) Ca2+ flux was measured from wild-type (thin black line), Y112-128F (thick gray line), or Y14F (thick black line) from DP or CD4SP gated thymocytes by flow
cytometry after CD3 and CD4 crosslinking (n = 6).be similar to that of Itk-deficient mice. Itk-deficient T cells exhibit
decreased ERK and PLCg1 phosphorylation and diminished
Ca2+ flux after TCR stimulation (Liu et al., 1998; Schaeffer
et al., 1999). Both Y145F and Y112-128F mice share these
characteristics (Figures 4D–4F). Recently, CD8SP thymocytes
from Itk-deficient mice were shown to express high amounts of
CD122 and CD44 and lowHSA levels (Atherly et al., 2006; Brous-
sard et al., 2006). Importantly, this cell-surface phenotype was
seen in CD8SP thymocytes from Y145F mice (Figure 5B). Ex-
pression of these markers was variably upregulated on Y112-
128F CD8SP thymocytes (and peripheral CD8+ T cells) but never
to amounts seen in Y145F mice (our unpublished data). More-
over, CD8SP thymocytes from Itk-deficient mice, but not wild-
type mice, express high amounts of eomesodermin mRNA
(Atherly et al., 2006). To determine whether altered eomesoder-
min regulation was also shared by Y145F and/or Y112-128F
thymocytes, we purified CD8SP CD69+ (a marker of recently se-
lected cells) thymocytes and performed real-time PCR. Eomeso-
dermin message expression was65-fold greater in Y145F than
in wild-type or Y112-128F purified cells (Figure 5C). Taken to-
gether, these data reveal that although Y112-128 and Y145 con-364 Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc.tribute similarly to TCR-inducedCa2+ flux and phosphorylation of
PLCg1 and ERK, Y112-128 and Y145 are differentially required
for Vav1 phosphorylation and phenotypes associated with Itk
deficiency, respectively, despite the preserved association of
mutated SLP76 with these binding partners.
Complementation of SLP76 Mutations In Vivo
Because Y112-128F and Y145F thymocytes show distinct differ-
ences in their abilities to support Vav1and Itk functions,weasked
whether thesemutants could complement one another function-
ally if they were coexpressed. To this end, we generated double-
mutant mice bearing one Y112-128F allele and one Y145F allele.
Double-mutant mice were compared to wild-type and SLP76
single-mutantmice inmultiple phenotypic and functional assays.
In all cases, responses of the double-mutant cells were greater
than those of either single-mutant mouse and, in some cases,
were identical to thoseobserved forwild-typemice. For example,
the CD5 and CD3 thymic profile of Y112-128F and Y145F mice
was strikingly abnormal; however, coexpression of the two mu-
tants resulted in nearly normal CD5 and CD3 expression
(Figure 6A). Functionally, the ability of double-mutant thymocytes
Immunity
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to flux Ca2+ was similar to or only slightly reduced from that
observed in wild-type thymocytes (Figures 6B–6D). We did not
observe a dominant-negative effect of expressing the Y112-
128F and Y145F mutations simultaneously, inasmuch as Vav1
phosphorylation, which was nearly normal in Y145Fmice but de-
fective in Y112-128F mice, was normal in the double mutant (our
unpublished data). Similarly, double-mutant CD8SP thymocytes
were not CD122+HSAlo, a phenotype of Y145F but not Y112-
128Fmice (Figure 6E). Thus, based on phenotypic and functional
data, these two distinct mutants of SLP76 can complement each
other in trans in developing thymocytes.
DISCUSSION
In this study we modified SLP76 to explore mechanisms by
which it supports TCR signaling and to understand how this
adaptor coordinates formation of a signaling complex. Expres-
sion of SLP76 harboring mutations at tyrosines 112 and 128 or
at tyrosine 145 revealed that these tyrosine ‘‘units’’ are important
for efficient pre-T cell signaling, NKT cell development, and ab
T cell selection. We also demonstrated that lack of a tyrosine
at position 145 results in the development of CD8+ innate-like
lymphocytes.
Optimal early signaling from the pre-TCR depends upon tyro-
sines 112 and 128 and on tyrosine 145, as evidenced by an in-
creased percentage of DN3 thymocytes and a failure to upregu-
late CD5 at the DP stage in the mutant mice (Azzam et al., 1998).
Once at the DP stage, thymocytes can either be selected into the
classical ab T cell pool or be selected into alternative (e.g., NKT)
lineages. SLP76 mutant mice generate NKT cells that express
near wild-type amounts of CD44 and HSA (our unpublished
data), indicating normal progression through the early stages
of NKT cell ontogeny. In contrast, upregulation of NK1.1 was di-
minished, most notably in the periphery. Failure to express
Figure 5. Thymocytes from Y112-128F and
Y145F Mice Have Distinctive Signaling
Defects
(A) Vav1 was immunoprecipitated from thymocyte
lysates, and phosphorylation of Vav1 was deter-
mined by immunoblotting with anti-phospho-tyro-
sine antibody (4G10). Total Vav1 was used as
a loading control (n = 3).
(B) Thymocytes from wild-type, Y112-128F,
Y145F, and Itk–/– mice were stained with anti-
CD4 and anti-CD8. CD8SP cells were evaluated
for expression of CD44 and CD122 (n > 7).
(C) CD8SP,CD69+ and CD4SP,CD69+ thymocytes
were purified by flow cytometry. cDNA from sorted
cells was generated and used for determining the
relative expression of eomesodermin in each
sorted population as compared to the expression
found in wild-type CD4SP CD69+ thymocytes (n =
2). Error bars represent maximum and minimum
RQ values.
NK1.1 was most marked in Y145F mice
and was similar to that observed on Itk-
deficient NKT cells (Gadue and Stein,
2002). From these data, we speculate that Y112-128 and Y145
are similarly required for pre-TCR signaling but that Y145 might
be preferentially required for the later stages of NKT develop-
ment, possibly through an Itk-dependent pathway.
Because SLP76-deficient thymocytes do not develop past the
DN3 stage, it has been difficult to study the role of SLP76 in pos-
itive and negative selection. We show here that point mutations
in this molecule can result in dramatic negative-selection defects
induced by self-peptide or endogenous superantigens. Both of
these models point to Y145 as being more critical for effective
negative selection. In fact, in HY Y145F males, there was an
increase in thymus size compared to that of wild-type controls
as well as an emergence of CD8SP thymocytes that express
relatively high amounts of the HY clonotype (our unpublished
data). Thus, it appears that in Y145F male mice, the HY antigen
is driving positive selection of HY clonotype+ thymocytes. The
difference in the efficiency of negative selection in Y112-128F
versus Y145F mice is probably not due to differential expression
of Nur77 because its upregulation was similarly defective in both
mutant lineages. Additionally, differences in positive and nega-
tive selection in Y112-128F versus Y145F mice cannot be attrib-
uted to a defective conjugate formation or actin polymerization
because both mutants again show similar defects in these
assays. Importantly, mice deficient in Itk and Vav1 also dem-
onstrate defects in these processes (Costello et al., 1999;
Krawczyk et al., 2002; Labno et al., 2003; Schaeffer et al., 1999).
Y112-128F mice had a near complete loss of Vav1 phosphor-
ylation after TCR stimulation. Y145F thymocytes, however, had
only subtle defects in Vav1 phosphorylation, yet the phenotype
of these cells was strikingly similar to that of Itk-deficient mice.
In fact, comparisons of the two revealed many similarities. One
similarity was the development of CD8 innate-like lymphocytes.
This thymocyte subset was recently found to preferentially
develop (in comparison to conventional CD8+ ab T cells) in
Itk-deficient mice (Atherly et al., 2006; Broussard et al., 2006).Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc. 365
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Trans Complementation of SLP76 Knock-In MutationsFigure 6. SLP76 Mutants Can Complement One Another In Trans
(A) Expression of CD3 versus CD5 on total thymocytes from wild-type, Y112-128F, Y145F, and double-mutant mice (n = 4).
(B) Histograms show the expression of Nur77 on DP thymocytes after 2 hr of stimulation with media alone (shaded histograms) or anti-CD3 + anti-CD28 (thick
black line) (n = 3).
(C) Lysates from anti-CD3-stimulated wild-type, Y112-128F, Y145F, and double-mutant thymocytes were analyzed by immunoblot for phosphorylation of PLCg1
and ERK (n = 3).
(D) Ca2+ flux was induced by crosslinking of CD3 and CD4. The tracings represent the relative amount of Ca2+ released in CD4SP thymocytes fromwild-type (thin
black line), the double-mutant (thick gray line), or Y112/1284F (thick gray line) and Y145F (thick black line) mice (n = 4).
(E) Contour plots show HSA versus CD122 expression on CD8SP thymocytes.The innate-like CD8SP cells present in Itk-deficient mice are
CD44hi and CD122hi, contain elevated amounts of eomesoder-
min mRNA, and produce high amounts of IFN-g upon ex vivo
stimulation. The CD8SP thymocytes from Y145F mice also
exhibit these characteristics. Although further analyses might re-
veal differences between Y145F and Itk-deficient mice, it is strik-
ing that a single point mutation in SLP76 results in a phenotype
that so closely mimics that of Itk deficiency; this result suggests
that many of the functions of Itkmight be largely dependent upon
SLP76. Tyrosines 112 and 128 might contribute to Itk activation
as well; these tyrosines are required for Vav1 phosphorylation,
and Vav1 is a known regulator of Itk (Reynolds et al., 2002).
This possibility might help to explain why CD8+CD44+ cells are
occasionally seen in Y112-128F mice.
A simplemodel for how theN-terminal tyrosines of SLP76 sup-
port thymocyte signaling is that each tyrosine binds its respec-
tive binding partner after tyrosine phosphorylation and thus
allows for the activation of associated enzymes. Indeed on the
basis of previous studies in Jurkat cells, we predicted that muta-
tion of tyrosines 112 and 128 or tyrosine 145 would abolish the
SLP76 and Vav1 or the SLP76 and Itk associations, respectively.
However, as noted, we saw constitutive association between
SLP76 and these two proteins in primary murine T cells, and
these associations did not appear to be dependent upon the
N-terminal tyrosines of SLP76.We speculate that although these
tyrosines are probably still important for binding to Itk and Vav1,366 Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc.their contributions are not appreciated in primary T cells because
of tertiary protein-protein interactions. Consistent with these
data, we did not see an appreciable increase in the binding of
Vav1 and Itk to SLP76 even in wild-type thymocytes after
TCR stimulation, although there was robust inducible SLP76
phosphorylation.
Although the molecular interactions responsible for the
protein-protein interactions observed in wild-type and mutant
mice are unclear, the selective loss of Vav1 phosphorylation in
Y112-128F thymocytes and the developmental similarities be-
tween Itk-deficient andY145F thymocytes suggest that the activ-
ity of these proteins is regulated by Y112-128 and Y145, respec-
tively. According to this model, Itk in Y145Fmice could associate
with SLP76 via tertiary interactions or perhaps directly through
the SH3 domain of Itk, as has been reported (Bunnell et al.,
2000). However, because of a lack of phosphorylation at position
145 of SLP76, Itk functionwould not be induced. Indeed, the SH2
domain of Itk has been proposed to require interaction with
a phosphotyrosine in order for Itk to acquire kinase activity (Plet-
neva et al., 2006). This failure to activate Itk would result in dimin-
ishedPLCg1phosphorylation andCa2+ flux (Liu et al., 1998). Sim-
ilarly, Vav1 might associate with a SLP76 complex via indirect
interactions; however, in the absence of Y112-128, Vav1 fails to
become phosphorylated. Although associated with SLP76, lack
of phosphorylation at Y112-128 might prevent Vav1 from under-
going a conformational change that is necessary for access by its
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Immunity 28, 359–369, March 2008 ª2008 Elsevier Inc. 367kinase. Lack of Vav1 phosphorylation might impact PLCg1 acti-
vation by affecting the Vav1-regulated, PI3K-dependent activa-
tion of Itk or the interaction betweenPLCg1 andSLP76 (Reynolds
et al., 2002). Determiningwhether tyrosines 112 and 128 regulate
GEF activity might help to distinguish between these two possi-
bilities. Although JNK (c-Jun N-terminal kinase) is a target of
Vav1 GEF activity in cell lines, we did not note a substantial
decrease in JNKphosphorylation (our unpublished data), consis-
tent with a prior study reporting normal JNK phosphorylation in
Vav1-deficient thymocytes (Fischer et al., 1998). Analysis of other
Vav1 GEF targets and direct assessment of both Vav1 and Itk
enzymatic activity are currently underway.
A great deal is known about the signaling pathways supported
by individual adaptor proteins. Much less is known about how
domains within a protein work together to support in vivo func-
tions. We addressed this question with regard to the N-terminal
tyrosines of SLP76 by attempting to genetically complement one
mutation with the other. Using phenotypic, functional, and bio-
chemical read-outs, we found that double-mutant mice partially
and in some instances fully rescued the single-mutant pheno-
types. Our data demonstrate that the tyrosines of SLP76 can
function independently and that the cooperativity between mu-
tant SLP76 molecules occurs early after TCR stimulation given
that Ca2+ flux and activation of proximal signaling molecules
were restored in double-mutant mice. Proteins that inducibly as-
sociate with SLP76 have been shown to oligomerize after TCR
stimulation. For example, the adaptor growth factor receptor-
bound protein 2 (Grb2) induces the oligomerization of linker of
activated T cells (LAT) after TCR ligation (Houtman et al.,
2006). SLP76 binds inducibly to LAT via the adaptor GADS
(Grb2-like adaptor downstream of Shc). Thus, it is likely that
the complex that forms subsequent to TCR ligation includes at
least two SLP76 molecules. The partial rescue seen in some
assays leads us to speculate that the trans complex is not as
stable as a cis complex or that recruitment or activation of other
key proteins to the signaling complex could be inefficient. This
idea is consistent with data from Itk knock-down Jurkat cells
and Vav1-deficient thymocytes, in which the absence of Itk or
Vav1 results in the destabilization of the SLP76 and Vav1 and
the SLP76 and PLCg1 associations, respectively (Dombroski
et al., 2005; Reynolds et al., 2002).
To our knowledge, these data describe the first example of
in vivo trans complementation by a lymphocyte adaptor protein.
In fact, these data contrast with the lack of complementation
seen between two mutations in the SLP76 homolog, BLNK
(B cell linker protein), in BLNK-deficient DT40 cells (Chiu et al.,
2002). Although these results could reflect differences between
primary T cells and B cell lines, they might be a consequence of
broader signaling differences downstreamof various ITAM-bear-
ing receptors. For example, TCRsignal transduction is supported
by ten ITAMs, utilizes theSyk kinaseZAP70, and is absolutely de-
pendent upon LAT (a protein known to oligomerize) (Zhang et al.,
1999). Conversely, B cells utilize only two ITAMs, signal through
Syk, and do not require LAT. Because SLP76 is not expressed
in mature B cells, a direct comparison of the ability of the Y112-
128F and Y145F mutations to complement one another in
B and T cells is not possible. However, SLP76 is expressed in
platelets, neutrophils, and mast cells. All of these cell types
depend upon SLP76 for proper ITAM-mediated signaling. Com-parisons in the ability of the tyrosine mutations described herein
to complement one another in trans in a variety of cell types are
currently underway and will probably provide unique insight
into how a single adaptor functions in distinct lineages.
EXPERIMENTAL PROCEDURES
Mice
Mutant mice were backcrossed to C57BL/6mice 2–5 times. Itk-deficient thymi
were the kind gift of Pamela Schwartzberg. All animal experiments were
preformed in accordance with the guidelines of the University of Pennsylvania.
Flow Cytometry
Thymocytes were harvested, washed, and stained with antibodies in FACS
buffer (PBS containing 2% FBS and 0.002% azide) for 30 min. Samples
were collected on a FACSCalibur (BD Biosciences), and analysis was per-
formed with FlowJo software (Tree Star). Fractionated thymic populations
were sorted on a BD FACSAria. Liver lymphocytes were isolated as previously
described (Watanabe et al., 1992). Antibodies for flow cytometry were
purchased from BD PharMingen: anti-CD4 PE or PerCpCy5.5, anti-CD8 allo-
phycocyanin or FITC, anti-CD3 PE, anti-Vb3 FITC, anti-Va11 PE, anti-Rat Ig
FITC, anti-Nur77, anti-CD122 PE, anti-CD44 FITC, anti-Vb6 FITC, anti-Vb8
FITC, anti-Vb11 PE, anti-Vb12 biotin followed by streptavidin PE, anti-B220
allophycocyanin or FITC, anti-ckit allophycocyanin, anti-CD25 PerCpCy5.5,
anti-Thy1.2 allophycocyanin, anti-ckit PE, anti-CD24 FITC, anti-TCRb allophy-
cocyanin, PE or FITC, anti-CD5 FITC, anti-CD2 PE, PBS57-CD1d tetramer-
allophycocyanin (NIH tetramer Core Facility), and NK1.1 PerCp. FITC-
conjugated lineage markers were as follows: anti-CD8, anti-gd, anti-DX-5,
anti-B220, anti-NK1.1, anti-Mac1, and anti-Gr1. Phalloidin-488was purchased
fromMolecularProbes.
Nur77 Upregulation and Coreceptor Downregulation
Freshly isolated thymocytes were plated (1 3 106 cells) onto a 24-well dish
coated with anti-CD3 (10 mg/ml) ± anti-CD28 (50 mg/ml). Cells were cultured
at 37C for 2 hr (Nur77) or 5 hr (coreceptor downregulation). For coreceptor
downregulation, cells were stained with anti-CD4 and anti-CD8 antibodies
and collected on a FACSCalibur. For Nur77 analysis, thymocytes were har-
vested and fixed (1% PFA for 10 min at room temperature) and permeabilized
in cold methanol for 30 min or overnight. Cells were rehydrated in PBS and
stained with anti-CD4, anti-CD8, and anti-Nur77 followed by anti-Rat Ig FITC
antibodies.
Vb Deletion
Mutant mice and heterozygous littermates were backcrossed to Balb/c mice
for three generations. C57BL/6, Sv129, and Balb/c mice all express MMTV-
8 and9 (Peterson et al., 1985; Salinas et al., 1987). Severalmice used in these
studies harbored an irrelevant hemagglutinin transgene that was carried
through the backcrosses for other purposes. Wild-type mice were back-
crossed 3–10 times. The percent DP and CD4SP thymocytes expressing
Vb6, 8, 11, and 12 was determined by flow cytometry.
Conjugate Formation
B cells (LK35.2) were incubated for 1 hr at 37C with anti-B220 with or without
10 mM PCC. Cells were washed and resuspended at 13 107 cells/ml. Spleno-
cytes were stained with anti-CD4, anti-CD8, and anti-Va11 antibodies,
washed, and resuspended to 1 3 107 cells/ml. Cells were mixed at a 1:1 ratio
(100 ml of each), spun in a Beckman tabletop centrifuge for 2min at 1200 rpm at
4C, and then placed in a 37C water bath for 12 min. The addition of cold
media containing 0.02% azide stopped conjugate formation. Cells were gently
mixed by being pipetted three times before collection on a BD FACSCalibur.
F-actin Staining
Thymocytes were rested in IMDM containing 1% BSA for 45 min and then
stained with 2 mg/ml anti-CD3 (2C11; PharMingen) on ice for 20 min. Cells
were washed and resuspended in warm PBS/1% BSA for 5 min, after which
cells were removed for the unstimulated time point. Anti-CD3 was crosslinked
with goat-anti-hamster (1 mg/ml) for various time points. Cells were fixed for
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5 min, washed, and stained with phalloidin, anti-CD4, and anti-CD8.
Immunoprecipitations and Immunoblots
Thymocytes were rested at 37C in IMDM (no serum) for 30 min, after which
they were stimulated with 5 mg/ml of anti-CD3 (500A2; PharMingen) at 37C
for various amounts of time. The addition of ice-cold PBS stopped the stimu-
lations. Cells were pelleted and lysed in buffer containing 1% NP-40, 150 mM
NaCl, 50 mM Tris HCl (pH 7.5), 1 mM Na3VO4, 5mM NaF, 1 mM PMSF, Prote-
ase Inhibitor Cocktail (Sigma), and 5 mM Na pyrophosphate. For immunopre-
cipitations, lysates were incubated, while rotating at 4, with either anti-SLP-76
(eBioscience) or anti-Vav1 (Cell Signaling) for 2–3 hr, after which 50 ml of anti-
mouse or anti-rabbit Trueblot beads (eBioscience) were added and the
mixture was incubated for an additional hour. Beads were washed four times
with lysis buffer and resuspended in 50 ml 23 Laemmli’s reducing buffer (Bos-
ton Bioproducts), boiled, and analyzed by immunoblot. Immunoblots were
probed with the following antibodies: 4G10 anti-phospho-tyrosine (Upstate),
phospho-PLCg-1 (Tyr783), PLCg-1, phospho-p44/42 MAPK (Thr202/
Tyr202), phospho-LAT (Tyr191) (all from Cell Signaling), ERK2 (Santa Cruz),
and phospho-SLP-76 (Tyr128) (BD Biosciences).
Ca2+ Flux
Thymocytes were loaded in RPMI containing 1% serum with 2 mg/ml of Indo-1
(Molecular Probes) in the presence of 4 mM probenecid at 30C for 30 min.
Cells were concurrently stained with biotinylated-2C11, biotinylated anti-
CD4 (clone RMA-4), anti-CD4 PE (clone GK1.5), and anti-CD8 FITC. Washed
cells were resuspended in serum-free RPMI and warmed to 37C, and
baseline Ca2+ levels were measured for 30 s before addition of streptavidin
(12.5 mg/ml) (Molecular Probes). Ca2+ release was measured by a change in
Indo-1 fluorescence; this change was represented by the ratio of bound to un-
bound Indo-1. An LSR Bench Top Flow Cytometer (BD Biosciences) was used
for data collection, and FlowJo software (Tree Star) was used for analysis.
Real-Time RT-PCR
CD4SPCD69+ andCD8SPCD69+ thymocyteswere purified by FACSwith anti-
CD8 FITC, anti-CD4-allophycocyanin, and anti-CD69-PE. Thymocytes were
washed and lysed with Trizol Reagent (Invitrogen). RNA was isolated with the
RNeasy kit according to the manufacturer’s protocol (QIAGEN). cDNA was
made with the Super Script III First Strand kit (Invitrogen). RT-PCR was per-
formed with the eomesodermin or GADPH primer/probemix from Applied Bio-
systems. Reactions were performed on a 7500 Fast Real-Time PCR System
withFastTaqMasterMix (AppliedBiosystems). For analysis, sampleswere nor-
malized to GAPDH levels and then set relative to normalized CD4SP CD69+
eomesodermin message levels (relative quantity, RQ). Calculations were per-
formed with Applied Biosystems software. Error bars represent the maximum
and minimum possible RQ values. All samples were performed in triplicate.
SUPPLEMENTAL DATA
Additional Experimental Procedures and four figures are available online
at http://www.immunity.com/cgi/content/full/28/3/359/DC1/.
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